SMA II
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients (NCT05901987) | GeneCradle Inc | 2023-08-01 |
| Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases (NCT04837157) | MarsiBionics | 2020-10-15 |
| Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral Palsy (NCT04813601) | MarsiBionics | 2020-03-09 |
| Paracetamol Study in Patients With Low Muscle Mass (NCT03648658) | Mette Cathrine Oerngreen | 2019-02-18 |
Track SMA II automatically
Every clearance here is in the API, with alerts when new ones post.